Easywell Biomedicals, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 71.639 million compared to TWD 77.836 million a year ago. Operating loss was TWD 53.680 million compared to TWD 45.244 million a year ago. Net income was TWD 5.057 million compared to net loss of TWD 45.791 million a year ago. Basic earnings per share was TWD 0.04 compared to basic loss per share of TWD 0.36 a year ago.